{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Hannah Kuchler", "title": "Novo Nordisk's obesity drug cuts risk of death by 18%, trial data shows - Financial Times", "description": "Wegovy found to have \u2018quite profound\u2019 effect on reducing risk of heart attacks, says pharma group", "url": "https://www.ft.com/content/a204a830-4c54-4832-94d8-62b040e6fd48", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252Fb3fd3067-a88f-41ba-8ddf-920f64269d31.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-11-11T13:30:15Z", "content": "Novo Nordisks weight-loss drug Wegovy cut the risk of death by 18 per cent in a trial that the Danish pharmaceutical company hopes will convince more health systems and insurers to pay for the treatm\u2026 [+2366 chars]"}]}